Medapp

Medapp Capital Expenditures

The Capital Expenditures (CapEx) of Medapp (MDA.WA) as of Nov 21, 2026 is -1.81 M PLN. In the previous year, Capital Expenditures (CapEx) was -3.48 M PLN — a change of -48.07% (higher).

Capital Expenditures

-1.81 MPLN

YoY

-48.07%

Last updated:

Capital Expenditures (CapEx) of Medapp is 2025 -1.81 M PLN. Capital Expenditures (CapEx) of Medapp was 2024 -3.48 M PLN. It decreases by -48.07% higher compared to the previous year.

The Medapp Capital Expenditures history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Expenditures
Date
Capital Expenditures
Jan 1, 2018
-74,610.00 PLN
Jan 1, 2019
0.00 PLN
Jan 1, 2020
-114,820.00 PLN
Jan 1, 2021
-240,000.00 PLN
Jan 1, 2022
-6.52 M PLN
Jan 1, 2023
0.00 PLN
Jan 1, 2024
-3.48 M PLN
Jan 1, 2025
-1.81 M PLN
The Medapp Capital Expenditures history
YEARCapital ExpendituresYoY
-1.81 MPLN-48.07%
-3.48 MPLN—
0.00PLN-100.00%
-6.52 MPLN+2,615.42%
-240,000.00PLN+109.02%
-114,820.00PLN—
0.00PLN-100.00%
-74,610.00PLN-96.22%
-1.97 MPLN+8,460.68%
-23,040.00PLN—
0.00PLN—
0.00PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medapp Stock analysis

What does Medapp do? MedApp SA generates revenue through its mobile marketing solutions in the medical field, primarily via the Carna Life software application. Carna Life functions as a telemedicine platform enabling doctors and patients to communicate, with features including data upload and download for test results, offline data review, and graphical statistics. The company serves healthcare providers and patients seeking telemedicine services, focusing on the Polish market through its Krakow headquarters. Moonrock Enterprise SA controls MedApp SA, leveraging its software for medical communication solutions. The firm's revenue model centers on the Carna Life application, which provides telemedicine services by facilitating secure data exchange between doctors and patients. Patients use the app to upload test results, while doctors interpret them through the platform, supported by offline functionality and data visualization tools. This system targets medical professionals and patients in Poland, operating within the telemedicine sector without external partnerships or additional branded products. MedApp SA's business relies solely on the Carna Life telemedicine system, which offers both online and offline modes for data management. The application includes statistics, visualizations, and tables for interpreted medical data, serving as a communication channel between healthcare providers and patients. Controlled by Moonrock Enterprise SA, the company monetizes its software through direct sales to medical institutions and patient users in the Polish healthcare market. Medapp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medapp stock

Capital Expenditures (CapEx) of Medapp is -1.81 M PLN in 2025.

Capital Expenditures (CapEx) of Medapp changed from -3.48 M PLN to -1.81 M PLN, representing a -48.07% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Capital Expenditures (CapEx) Medapp since 2006 – with annual values, charts, and detailed analysis.

Capital expenditures represent investments in long-term assets such as property, equipment, and technology. CapEx is essential for maintaining and growing the business.

Capital Expenditures (CapEx)'s PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Capital Expenditures (CapEx)'s Medapp historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Medapp

All Key Metrics — Medapp